Literature DB >> 27441781

Optical Coherence Tomography in High Myopia.

Joel S Schuman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27441781      PMCID： PMC5457792          DOI： 10.1001/jamaophthalmol.2016.2017

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  2 in total

Review 1.  Glaucoma versus red disease: imaging and glaucoma diagnosis.

Authors:  Gabriel T Chong; Richard K Lee
Journal:  Curr Opin Ophthalmol       Date:  2012-03       Impact factor: 3.761

2.  Evaluation of a Myopic Normative Database for Analysis of Retinal Nerve Fiber Layer Thickness.

Authors:  Sayantan Biswas; Chen Lin; Christopher K S Leung
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389
  2 in total
  5 in total

Review 1.  [Secondary diseases in high myopia].

Authors:  F Ziemssen; W Lagrèze; B Voykov
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

2.  Alterations in the Retinal Nerve Fiber Layer Thickness Color Map in Non-Glaucomatous Eyes with Myopia.

Authors:  Hayati Yılmaz; Mehmet Talay Köylü; Yağmur Seda Yeşiltaş; Dorukcan Akıncıoğlu; Duygu Yalınbaş; Yeşim Gedik Oğuz; Atilla Bayer; Fatih Mehmet Mutlu
Journal:  Turk J Ophthalmol       Date:  2021-02-26

3.  Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study.

Authors:  J Rezapour; S Nickels; A K Schuster; M Michal; T Münzel; P S Wild; I Schmidtmann; K Lackner; A Schulz; N Pfeiffer; M E Beutel
Journal:  BMC Ophthalmol       Date:  2018-06-28       Impact factor: 2.209

Review 4.  Optical Coherence Tomography and Glaucoma.

Authors:  Alexi Geevarghese; Gadi Wollstein; Hiroshi Ishikawa; Joel S Schuman
Journal:  Annu Rev Vis Sci       Date:  2021-07-09       Impact factor: 7.745

5.  Optical Coherence Tomography Can Be Used to Assess Glaucomatous Optic Nerve Damage in Most Eyes With High Myopia.

Authors:  Zane Z Zemborain; Ravivarn Jarukasetphon; Emmanouil Tsamis; Carlos G De Moraes; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2020-10       Impact factor: 2.290
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.